alexa Biological Activity in Drug Discover
ISSN: 2161-0444

Medicinal chemistry
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

Special Issue: Biological Activity in Drug Discover

Pharmacological biological activity refers to the physiological implications (adverse and beneficial) of pharmaceutical agents. The study of biological activity of each and every clinically applicable drug that includes the intended biological response as well as side effects is crucial to access the immediate and long term impacts of administration of a specific drug or a combination of drugs.
Safety assessment of drugs especially when it is administered in conjunction with other drugs is crucial in gaining the approval of medical authorities for its widespread clinical recommendation. Hence, study of pharmacological biological activity is quite possibly the most important step in the process of drug discovery.
Furthermore, the recent technological advancements, especially in the field of bioinformatics and computational modeling enable medical researchers to design and adopt the bottom up approach to identify and synthesize novel pharmaceutical agents that possess the desired properties and physiological implications. To highlight the scientific and practical importance of biological activities, the Journal of Medicinal Chemistry is hosting a special issue titled “Biological Activity in Drug Discovery”.
The special issue will publish original scientific manuscripts that are based on recent developments made in the field of study and application of pharmacological bioactivity information in the process of drug discovery. This special issue is pledged to publish research manuscripts that are directly or indirectly related to any/all of the below mentioned scientific disciplines:

  • Cytotoxicity and genotoxicity
  • Bio-mineralization
  • Physical and chemical properties of drugs
  • Drug affinity and selectivity
  • Bioavailability
  • Clinical trials
  • Computer aided drug designing
  • Reverse pharmacology

The special issue is aimed to contribute to the furtherance of drug delivery research with special emphasis on the biosafety of the conventionally used and recently developed pharmaceutical formulations.
Due date of the submission: 15 June 2017
Publication date: September 2017

Youngjae You

Youngjae You

Associate Professor
University of Oklahoma Health Sciences Center                      
Oklahoma City

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version